Clinical trial
Phenotypic and Transcriptomic Description of Megakaryocytes in Sickle Cell Patient
NCT06887907 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phenotypic and Transcriptomic Description of Megakaryocytes in Sickle Cell Patient
- Lead sponsor
- University Hospital, Toulouse
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 13, 2025
- Completion date
- April 1, 2028
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease (scd)